[144] Symbotic Inc. SEC Filing
Rhea-AI Filing Summary
Symbotic Inc. (SYM) filed a Form 144 reporting a proposed sale of 10,345 Class A common shares through Morgan Stanley Smith Barney, with an aggregate market value of $576,482.37 and an approximate sale date of 08/08/2025 on NASDAQ. The filing shows these shares were acquired on 08/08/2025 as restricted stock vesting under a registered plan and were paid as services rendered.
The notice also discloses prior sales by Miriam Ort totaling 30,525 shares in the past three months, with gross proceeds of $270,977.78 on 07/24/2025 and $651,088.37 combined on 06/12/2025. The filer certifies they are not aware of undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 sale and recent insider dispositions disclosed; transaction sizes disclosed are modest.
The Form 144 documents a planned brokered sale of 10,345 Class A shares valued at $576,482.37 to be executed on NASDAQ on 08/08/2025. The shares were acquired via restricted stock vesting and tied to services rendered, which is a common executive compensation outcome. The filing also itemizes three recent disposals by Miriam Ort totaling 30,525 shares with aggregate proceeds shown. This filing provides transparency on insider liquidity but contains no operational or financial performance data.
TL;DR: Compliance-focused disclosure; indicates controlled insider selling under Rule 144 rather than a sudden governance event.
The notice shows compliance with Rule 144 procedures by routing the sale through Morgan Stanley Smith Barney and including acquisition details and past sales. The reported shares were issued via restricted stock vesting under a registered plan, suggesting planned compensation-related transfers. The signature representation that no material adverse information is known is standard. There is no indication in the filing of governance changes or regulatory concerns.